Home›Breast Cancer›PALB2 Germline Mutations Moderately Increased Risk of PALB2-Related Breast Cancer in China

PALB2 Germline Mutations Moderately Increased Risk of PALB2-Related Breast Cancer in China

January 19, 2022

170

This study analyzed the full prevalence and spectrum of partner and localizer BRCA2 (PALB2) germline mutations in China, focusing on the associations between these PALB2 germline mutations and breast cancer risk.

Fitcoachion

Problem solver. Creator. Thinker. Web nerd. Food enthusiast. Pop culture junkie. Snowboarder, dreamer, hiphop head, hand letterer and growthhacker. Producing at the crossroads of modernism and programing to express ideas through design. I am 20 years old.